Medicine
Sugammadex 200 mg/2 mL injection
Sugammadex 200 mg/2 mL injection is a generic prescription medicine for intravenous use, made by 2 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 25°C (77°F), excursions permitted to 15°C to 30°C (59°F to 86°F)…
Key facts
- Active ingredient (INN)
- Sugammadex
- Brand
- Sold under the generic name
- Strength
- 200 mg/2 mL
- Dosage form
- Injection
- Route
- Intravenous
- Origin register
- US FDA, United States
- Storage
- Store at 25°C (77°F), excursions permitted to 15°C to 30°C (59°F to 86°F). Protect from light. When not protected from light, the pre-filled syringe should be used within 5 days.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- V03AB35 Sugammadex
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 28 July 2026
- Identifiers
- RxCUI 2748156, 2748158DailyMed set ID 0379799d-b678-4eb1-8f15-7dd183ee2a6e, 579a2a1f-4d0c-4851-e063-6294a90a2be6NDC 82449-241, 42023-830Application ANDA218814
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 10 vial, single-dose in 1 carton / 2 mL in 1 vial, single-dose | 70710-1650-6 | — | 2 July 2026 |
| 10 vial, single-dose in 1 carton / 2 mL in 1 vial, single-dose | 70771-1856-6 | — | 2 July 2026 |
| 10 vial, single-dose in 1 carton / 2 mL in 1 vial, single-dose | 16729-726-03 | — | 4 August 2026 |
| 10 vial, single-dose in 1 carton / 2 mL in 1 vial, single-dose | 31722-254-10 | — | 27 July 2026 |
| 10 vial, single-dose in 1 carton / 2 mL in 1 vial, single-dose | 43598-924-26 | — | 28 July 2026 |
| 10 vial, single-dose in 1 carton / 2 mL in 1 vial, single-dose | 68083-441-10 | — | 28 July 2026 |
| 10 vial, single-dose in 1 carton / 2 mL in 1 vial, single-dose | 68462-695-20 | — | 28 July 2026 |
| 10 vial, single-dose in 1 carton / 2 mL in 1 vial, single-dose | 70748-370-02 | — | 28 July 2026 |
| 10 vial, single-dose in 1 carton / 2 mL in 1 vial, single-dose | 72205-478-02 | — | 28 July 2026 |
| 10 vial, single-dose in 1 carton / 2 mL in 1 vial, single-dose | 62756-079-02 | — | 28 July 2026 |
| 40 box in 1 case / 10 vial in 1 box / 2 mL in 1 vial | 0264-8200-10 | — | 28 July 2026 |
| 10 vial, single-dose in 1 carton / 2 mL in 1 vial, single-dose | 72266-268-10 | — | 29 July 2026 |
| 24 syringe in 1 carton / 2 mL in 1 syringe | 76045-219-20 | — | 28 July 2026 |
| 24 syringe in 1 carton / 2 mL in 1 syringe | 76045-219-24 | — | 28 July 2026 |
| 10 syringe in 1 carton / 2 mL in 1 syringe | 0641-6270-10 | — | 28 July 2026 |
| 10 vial, single-dose in 1 carton / 2 mL in 1 vial, single-dose | 83301-0077-2 | — | 2 November 2026 |
| 10 vial, single-dose in 1 carton / 2 mL in 1 vial, single-dose | 67457-969-02 | — | 28 July 2026 |
| 10 vial in 1 carton / 2 mL in 1 vial | 25021-619-02 | — | 1 July 2026 |
| 10 vial, single-dose in 1 carton / 2 mL in 1 vial, single-dose | 0781-3468-95 | — | 28 July 2026 |
| 10 vial, single-dose in 1 carton / 2 mL in 1 vial, single-dose | 42677-311-10 | — | 1 May 2025 |
| 10 vial, single-dose in 1 carton / 2 mL in 1 vial, single-dose | 55579-892-10 | — | 28 July 2026 |
| 10 vial, single-dose in 1 carton / 2 mL in 1 vial, single-dose | 70069-892-10 | — | 28 July 2026 |
| 1 vial, single-dose in 1 bag / 2 mL in 1 vial, single-dose | 71872-7382-1 | — | 9 September 2026 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Sugammadex 200 mg/2 mL injection.
Other strengths and forms of Sugammadex
Clinical summary
Sugammadex is a prescription medicine indicated for the reversal of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide in adult and pediatric patients undergoing surgery. It is available as injection for intravenous use. MedsAcross supplies Sugammadex for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about SugammadexFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- BRIDION prescribing information (Merck Sharp & Dohme) · U.S. National Library of Medicine, DailyMed
- Bridion: European public assessment report (EPAR) · European Medicines Agency
- Sugammadex Adroiq: European public assessment report (EPAR) · European Medicines Agency
Need Sugammadex 200 mg/2 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.